4.8 Article

Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?

Related references

Note: Only part of the references are listed.
News Item Multidisciplinary Sciences

ROGUE ANTIBODIES COULD BE DRIVING SEVERE COVID-19

Roxanne Khamsi

Summary: Evidence suggests that self-attacking autoantibodies may be crucial in understanding some of the most severe cases of SARS-CoV-2 infection.

NATURE (2021)

Article Biochemistry & Molecular Biology

Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation

Stefan R. Bornstein et al.

MOLECULAR PSYCHIATRY (2020)

Review Immunology

Covid-19 and autoimmunity

Michael Ehrenfeld et al.

AUTOIMMUNITY REVIEWS (2020)

Article Medicine, General & Internal

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption

Markus Toelle et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Editorial Material Multidisciplinary Sciences

A negative COVID-19 test does not mean recovery

Nisreen A. Alwan

NATURE (2020)

Article Multidisciplinary Sciences

Immunoadsorption to remove β2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME

Carmen Scheibenbogen et al.

PLOS ONE (2018)

Article Immunology

Chronic fatigue syndrome, the immune system and viral infection

A. S. Bansal et al.

BRAIN BEHAVIOR AND IMMUNITY (2012)

Review Medicine, General & Internal

CURRENT CONCEPTS Predisposing Factors for Adrenal Insufficiency

Stefan R. Bornstein

NEW ENGLAND JOURNAL OF MEDICINE (2009)